Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

June 19, 2027

Study Completion Date

June 19, 2027

Conditions
Acute Myeloid Leukemia
Interventions
OTHER

Biobanking blood

Additional volume of 30mL (EDTA) At Screening, pre-Cycle 1 Day 1,Day 1 H8, Day 2, Day of post-cycle 1 and post-cycle 6 evaluation.

OTHER

Bone marrow specimens

"Additional volume of 2mL (EDTA)~* at screening for correlative studies,at Day 7 for smears and for correlative studies.~* Post-cycle 1 and post-cycle 6 evaluations for correlative studies.~Optionnal :~Trephine biopsy at screening and at post-cycle 1 and 6 evaluations (performed at the same time as aspiration)"

Trial Locations (1)

Unknown

RECRUITING

Hôpital Saint Louis, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER